K

Kardigan

Biotech firm developing cardiovascular medicines

Director, GCP Inspection Readiness and Audits Strategy

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timePrinceton, NJ, USA$194k - $250k

About the Job

Requirements

  • A bachelor's degree in Life Sciences or a related discipline is required.
  • At least 10 years of relevant experience in clinical trials is required.
  • Direct senior-level experience supporting or leading inspection readiness activities, particularly in GCP and FDA BIMO contexts, is required.
  • Experience with clinical development compliance expectations is required, including sponsor oversight, CRO/vendor oversight, investigator site oversight, IRBs/ethics committees, monitoring, informed consent, protocol deviations, safety reporting, documentation quality, and data integrity.
  • Experience in a growing biotechnology company or sponsor organization with evolving processes, roles, and governance is required.
  • Strong communication, facilitation, stakeholder management, influencing, and executive-level briefing skills are required.
  • Ability to operate effectively in ambiguity and adjust quickly as organizational priorities evolve is required.

Responsibilities

  • Establish a practical framework for continuous inspection readiness that balances regulatory expectations with Kardigan’s stage and evolving portfolio.
  • Partner with Clinical Quality Leads to embed inspection readiness into program and functional execution rather than treating it as a separate Quality-owned activity.
  • Lead cross-functional alignment on holistic inspection risks, prioritizing areas requiring proactive readiness, mitigation, or leadership attention.
  • Adapt inspection readiness strategy as organizational priorities, development programs, or regulatory expectations evolve.
  • Define and implement tools, templates, and training to support inspection readiness and inspection management.
  • Partner with functional leaders to ensure subject matter experts, document owners, inspection support teams, and leadership stakeholders understand their roles before and during inspections.
  • Oversee readiness exercises, mock inspections, inspection simulations, and targeted coaching.
  • Ensure readiness activities support BIMO inspection expectations, including sponsor oversight, clinical site oversight, CRO/vendor oversight, IRB/ethics committee interactions, clinical documentation, and data integrity.
  • Partner with Quality and functional leaders to define the inspection management model, including front room, back room, strategy room, documentation support, communication flow, escalation, and response governance.
  • Evaluate and support inspection readiness for Prolaio if needed.
  • Partner with Clinical Quality Assurance to develop and maintain a risk-based annual audit plan aligned with program priorities, regulatory expectations, and emerging inspection risks.
  • Monitor regulatory trends, inspection findings, enforcement actions, and industry practices to inform audit strategies.
  • Drive execution of the aligned audit plan through effective planning, coordination, and follow-up.
  • Monitor audit progress, outcomes, trends, and resourcing needs, and course-correct with Clinical Quality Assurance when priorities or risks change.
  • Establish and maintain a qualified pool of external auditors to support audit execution and specialized subject matter needs.
  • Provide oversight and strategic input on audit scope, prioritization, issue escalation, and audit-related risk mitigation.
  • Lead or support audits directly when appropriate based on business need, expertise, and availability.

Desired Qualifications

  • Experience with medical devices used in clinical trials is strongly preferred.

About the Company

Kardigan

Biotech firm developing cardiovascular medicines

Kardigan develops medicines to prevent and treat cardiovascular disease. It focuses on discovering and developing multiple cardiovascular therapies at a rapid pace, using deep expertise in heart-health drug development to move candidates from research toward commercialization. Their product approach centers on creating medicines that address heart disease more effectively and earlier in the disease process. Kardigan differentiates itself through a leadership team of seasoned biopharma veterans and a commitment to modernizing how cardiovascular drugs are discovered and developed, aiming to bring therapies to patients faster and more efficiently. The company’s goal is to reduce the global burden of cardiovascular disease by providing safe, effective medicines that prevent progression or cure conditions related to heart health.

Company size
201-500
Company stage
IPO
Headquarters
West Windsor Township, NJ
Founded
2023

Recently Posted Jobs

Explore more opportunities at Kardigan

See more jobs